Sarepta therapeutics, inc. (srpt) investigation: bronstein, gewirtz & grossman, llc encourages investors to contact the firm to learn more about the investigation

New york, ny / access newswire / march 31, 2025 / bronstein, gewirtz & grossman, llc is investigating potential claims on behalf of purchasers of sarepta therapeutics, inc. ("sarepta" or "the company") (nasdaq:srpt). investors who purchased sarepta securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/srpt.
SRPT Ratings Summary
SRPT Quant Ranking